Influence of antibiotic and E5 monoclonal immunoglobulin M interactions on endotoxin release from Escherichia coli and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 247-252

  Lamp, Kenneth C ^a,b,e   Rybak, Michael J ^c,d   Mcgrath, Betty J ^c,d   Summers, Kim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DETROIT RECEIVING HOSPITAL   (United States)

^e VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTAZIDIME; ENDOTOXIN; IMIPENEM; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; OFLOXACIN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; DRUG EFFECT; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK;

EID: 0030031437     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.247     Document Type: Article

References (22)

1. Arditi, M., W. Kabat, and R. Yogev. 1993 Antibiotic-induced bacterial killing stimulates tumor necrosis factor-α release in whole blood. J. Infect. Dis. 167: 240-244.
2. Bone, R. C. 1991. The pathogenesis of sepsis Ann Intern. Med. 115:457-469.
3. Brandtzaeg, P., P. Kierulf, P. Gaustad, A. Skulberg, J. N. Bruun, S. Halvorsen, et al. 1989. Plasma endotoxins as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159:195-204
4. Casey, L. C., R. A. Balk, and R. C. Bone. 1993 Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann. Intern. Med. 119:771-778
5. Dofferhoff, A. S. M., M. T. Esselink, H. G. de Vries-Hospers, A. V. Zanten, V. J. J. Bom, J. Weits, and E. Vellenga. 1993 The release of endotoxin from antibiotic-treated Eschenchia coli and the production of tumour necrosis factor by human monocytes. J. Antimicrob. Chemother. 31:373-384.
6. Dofferhoff, A. S. M., J. H. Nijland, H. G. de Vries-Hospers, P. O. M. Mulder, J. Weits, and V. J. J. Bom. 1991. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria an in-vitro and in-vivo study. Scand. J. Infect. Dis 23:745-754
7. Dougherty, P. F., D. W. Yotter, and T. R. Matthews. 1976. Chemically defined medium for susceptibility testing of antimicrobial agents. Antimicrob. Agents Chemother. 10:923-925
8. Edmond, D. M., I. R, Poxton, and F. Padova. 1993. The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli grown in sub-MICs of temocillin and other antibiotics. J. Antimicrob. Chemother. 31:673-680
9. Eng, R. H. K., S. M. Smith, P. Fan-Havard, and T. Ogbara. 1993. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn. Microbiol. Infect. Dis. 16:185-189.
10. Evans, M. E., and M. Pollack. 1993 Effect of antibiotic class and concentration on the release of lipopolysaccharide from Escherichia coli. J. Infect Dis 167:1336-1343
11. Greenman, R. L., R. M. H. Schein, M. A. Martin, R. P. Wenzel, N. R. MacIntyre, G. Emmanuel, H. Chmel, R. B. Kohler, M. McCarthy, J. Plouffe, J. A. Russell, and the XOMA Sepsis Study Group. 1991. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266:1097-1102.
12. Guidet, B., V. Barakett, T. Vassal, J. C. Petit, and G. Offenstadt. 1994. Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit Chest 106:1194-1201.
13. Jackson, J. J., and H. Kropp. 1992. β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect. Dis. 165:1033-1041.
14. Kreger, B. E., D. E. Craven, and W. R. McCabe. 1980. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am. J. Med. 68:344-355.
15. Levin, J., P. A. Tomasulo, and R. S. Oser. 1970. Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab. Clin. Med. 75:903-911.
16. McCloskey, R. V., R. C. Straube, C. Sanders, S. M. Smith, C. R. Smith, and the CHESS Trial Study Group. 1994. Treatment of septic shock with human monoclonal antibody HA-1A. Ann. Intern. Med. 121:1-5.
17. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically Approved standard. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Shenep, J. L., R. P. Barton, and K. A. Mogan. 1985. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gramnegative bacterial sepsis. J. Infect. Dis 151:1012-1018.
19. Van den Berg, C., A. J. de Neeling, C. S. Schot, W. N. M. Hustinx, J. Werner, and D. J. de Wildt. 1992 Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand. J Infect. Dis. 24:619-627.
20. Waage, A., A. Halstensen, and T. Espevik. 1987 Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i:355-357.
21. Warren, H. S., R. L. Danner, and R. S. Mumford. 1912. Anti-endotoxin monoclonal antibodies. N. Engl. J. Med. 326:1153-1157.
22. Ziegler, E. F., C. J. Fisher, C. L. Sprung, R. C. Straube, J. C. Sadoff, G. E. Foulke, C. H. Wortel, M. P. Fink, R. P. Dellinger, N. N. H. Teng, I. E. Allen, H. J. Berger, G. L. Knatterud, A. F. LoBuglio, C. R. Smith, and the HA-1A Sepsis Study Group. 1991. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin N. Engl. J Med. 324:429-436